Related Experiment Video
Updated: Jan 7, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Prediction of Heart Failure Hospitalization or Death After TAVR
Bassim El-Sabawi1, Pratik Manandhar2, Javed Butler3,4
1Division of Cardiovascular Medicine, Department of Medicine (B.E.-S., J.L., A.L., B.R.L.), Vanderbilt University Medical Center, Nashville, TN.
A new clinical prediction model identifies patients at high risk of heart failure (HF) hospitalization or death after transcatheter aortic valve replacement (TAVR). This tool aids in guiding patient monitoring and treatment strategies post-TAVR.
Area of Science:
- Cardiology
- Medical Prediction Models
- Health Services Research
Background:
- Heart failure (HF) significantly impacts survival and quality of life after transcatheter aortic valve replacement (TAVR).
- Identifying patients at high risk for HF post-TAVR is crucial for timely intervention.
- Current methods for risk stratification in this population are insufficient.
Purpose of the Study:
- To develop and internally validate a clinical prediction model.
- To estimate the 1-year risk of HF hospitalization or death following TAVR.
- To identify patients who may benefit from closer monitoring or adjunctive therapies.
Main Methods:
- Analysis of a large registry of patients undergoing TAVR for aortic stenosis.
- Utilized hierarchical cumulative odds regression modeling.
- Predicted a composite outcome of all-cause death, multiple HF readmissions, or single HF readmission within 1 year.
Main Results:
- The model demonstrated good discrimination (C-statistic 0.753 derivation, 0.747 validation).
- 17.4% of patients experienced the composite outcome (death, HF readmission).
- A simplified 12-variable model maintained comparable predictive performance.
Conclusions:
- The developed model effectively stratifies patients by 1-year risk of death or HF hospitalization post-TAVR.
- This tool can guide clinical surveillance and patient selection for clinical trials.
- Supports the development of targeted medical therapies to mitigate post-TAVR adverse events.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure III: Clinical Manifestations
Heart Failure VI: Adjunct Therapies
Heart Failure I: Introduction
Heart Failure II: Pathophysiology